NephroGenex Announces Date Of Conference Call To Discuss Third Quarter 2014 Financial Results

NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, will report its third quarter 2014 financial results on Wednesday, November 12, 2014 after the U.S. financial markets close. The Company will host a conference call the following day, Thursday, November 13, 2014 at 8 a.m. Eastern, to review the third quarter 2014 financial results and provide an update on its PIONEER program for diabetic nephropathy and milestones for the remainder of 2014.

Help employers find you! Check out all the jobs and post your resume.